Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Sonoma Pharmaceuticals Q4 EPS $(0.07) Up From $(0.31) YoY, Sales $3.44M Miss $3.98M Estimate

Author: Benzinga Newsdesk | June 17, 2024 05:02pm

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share. This is a 77.42 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $3.44 million which missed the analyst consensus estimate of $3.98 million by 13.59 percent. This is a 14.10 percent increase over sales of $3.01 million the same period last year.

Posted In: SNOA